SCHEMBL7260720

SCHEMBL7260720

CCCCOC(=O)NC(C(=O)O)C(CC)c1ccc(Nc2nccc3ccncc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 4/20 0.39
HPGD P15428 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
EGFR P00533 2/20 0.38
KDR P35968 2/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SPHK1 Q9NYA1 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP26A1 O43174 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CSNK2A1 P68400 2/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2990959 0.87 EGFR (0.38) EGFRCSNK2A1CSNK2A2CSNK2BCYP3A4
SCHEMBL5147804 0.81 EGFR (0.38) EGFRKDRCSNK2A1CSNK2A2CSNK2B
SCHEMBL5147750 0.79 RAB9A (0.37) MAPTTP53RAB9ASMN1; SMN2NPC1
SCHEMBL7260715 0.78 EGFR (0.39) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL7610217 0.77 LMNA (0.50) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL7260724 0.76 EGFR (0.39) MAPTTP53RAB9ASMN1; SMN2NPC1
SCHEMBL5224258 0.75 SMN1; SMN2 (0.51) RAB9ASMN1; SMN2NPC1HPGDL3MBTL1
SCHEMBL3833596 0.73 MEN1 (0.32) RAB9ASMN1; SMN2NPC1L3MBTL1MEN1
SCHEMBL6131672 0.73 ITGB1 (0.38) CSNK2A1CSNK2A2CSNK2B
SCHEMBL3832798 0.73 ITGB1 (0.38) CSNK2A1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370531-A1 PHENYLALANINE ENAMIDE DERIVATIVES POSSESSING A CYCLOBUTENE GROUP, FOR USE AS INTEGRIN INHIBITORS Celltech R & D Limited (GB) 2003-12-17 EP disclosed
WO-2002068393-A1 PHENYLALANINE ENAMIDE DERIVATIVES POSSESSING A CYCLOBUTENE GROUP, FOR USE AS INTEGRIN INHIBITORS CELLTECH R & D LIMITED (GB) 2002-09-06 WO disclosed